AT387716B - Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen - Google Patents

Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen

Info

Publication number
AT387716B
AT387716B AT0058085A AT58085A AT387716B AT 387716 B AT387716 B AT 387716B AT 0058085 A AT0058085 A AT 0058085A AT 58085 A AT58085 A AT 58085A AT 387716 B AT387716 B AT 387716B
Authority
AT
Austria
Prior art keywords
alphaergocriptin
bromine
compositions
producing
bromine alphaergocriptin
Prior art date
Application number
AT0058085A
Other languages
German (de)
English (en)
Other versions
ATA58085A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA58085A publication Critical patent/ATA58085A/de
Application granted granted Critical
Publication of AT387716B publication Critical patent/AT387716B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0058085A 1984-02-29 1985-02-27 Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen AT387716B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (2)

Publication Number Publication Date
ATA58085A ATA58085A (de) 1988-08-15
AT387716B true AT387716B (de) 1989-03-10

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0058085A AT387716B (de) 1984-02-29 1985-02-27 Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen

Country Status (26)

Country Link
JP (1) JPS60202812A (pl)
AT (1) AT387716B (pl)
AU (2) AU586621B2 (pl)
BE (1) BE901810A (pl)
CA (1) CA1256374A (pl)
CH (2) CH666406A5 (pl)
DE (1) DE3505743C2 (pl)
DK (1) DK175016B1 (pl)
ES (1) ES8705223A1 (pl)
FR (1) FR2560047B1 (pl)
GB (1) GB8405227D0 (pl)
GR (1) GR850506B (pl)
HK (1) HK85490A (pl)
HU (1) HU196121B (pl)
IE (1) IE58235B1 (pl)
IL (1) IL74459A (pl)
IT (1) IT1199948B (pl)
LU (1) LU85791A1 (pl)
MX (1) MX9203626A (pl)
NL (1) NL194231C (pl)
NZ (1) NZ211247A (pl)
PH (1) PH23266A (pl)
PT (1) PT80015B (pl)
SE (2) SE462259B (pl)
SG (1) SG69390G (pl)
ZA (1) ZA851546B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB905000A (en) * 1960-06-06 1962-09-05 American Home Prod Improvements in and relating to sustained and delayed release oral medicaments
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
US4225605A (en) * 1977-12-22 1980-09-30 Sandoz Ltd. Ergolene or ergoline compounds for treating congestive heart failure
DE3246492A1 (de) * 1981-12-18 1983-06-30 Forest Laboratories Inc., 10022 New York, N.Y. Verfahren zur herstellung therapeutischer praeparate auf der basis von hydroxypropylmethylzellulose mit verlaengertem freisetzungsverlauf
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB905000A (en) * 1960-06-06 1962-09-05 American Home Prod Improvements in and relating to sustained and delayed release oral medicaments
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
US4225605A (en) * 1977-12-22 1980-09-30 Sandoz Ltd. Ergolene or ergoline compounds for treating congestive heart failure
DE3246492A1 (de) * 1981-12-18 1983-06-30 Forest Laboratories Inc., 10022 New York, N.Y. Verfahren zur herstellung therapeutischer praeparate auf der basis von hydroxypropylmethylzellulose mit verlaengertem freisetzungsverlauf
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung

Also Published As

Publication number Publication date
DK86785D0 (da) 1985-02-26
MX9203626A (es) 1992-09-01
JPS60202812A (ja) 1985-10-14
PT80015B (pt) 1987-09-18
IL74459A (en) 1988-12-30
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
GB8405227D0 (en) 1984-04-04
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
FR2560047A1 (fr) 1985-08-30
CA1256374A (en) 1989-06-27
PH23266A (en) 1989-06-23
IT1199948B (it) 1989-01-05
NL194231C (nl) 2001-10-02
DK86785A (da) 1985-08-30
SE8500961L (sv) 1985-08-30
HK85490A (en) 1990-10-25
IT8547703A0 (it) 1985-02-20
NL8500417A (nl) 1985-09-16
AU618599B2 (en) 1992-01-02
CH666406A5 (de) 1988-07-29
DK175016B1 (da) 2004-04-26
ZA851546B (en) 1986-10-29
IE58235B1 (en) 1993-08-11
ES8705223A1 (es) 1987-05-01
CH667009A5 (de) 1988-09-15
SE8500961D0 (sv) 1985-02-27
BE901810A (fr) 1985-08-26
AU3500689A (en) 1989-09-14
HU196121B (en) 1988-10-28
DE3505743A1 (de) 1985-08-29
IL74459A0 (en) 1985-05-31
AU3913685A (en) 1985-09-05
ATA58085A (de) 1988-08-15
HUT38254A (en) 1986-05-28
SE462259B (sv) 1990-05-28
IE850495L (en) 1985-08-29
GR850506B (pl) 1985-06-28
JPH0448776B2 (pl) 1992-08-07
SG69390G (en) 1990-10-26
DE3505743C2 (de) 1995-02-16
AU586621B2 (en) 1989-07-20
FR2560047B1 (fr) 1988-01-15
NZ211247A (en) 1989-02-24
LU85791A1 (fr) 1985-12-11

Similar Documents

Publication Publication Date Title
DE3587442D1 (de) Verfahren zur herstellung von polysilsesquioxanen.
DE3581200D1 (de) Verfahren zur herstellung von 1-hydroxyvitamin-d-verbindungen.
DE3585687D1 (de) Verfahren zur herstellung von 1-hydroxyvitamin-d-verbindungen.
DE3575423D1 (de) Verfahren zur herstellung von heteroaryloxyacetamiden.
DE3586638D1 (de) Verfahren zur herstellung von vanadylphthalocyanin.
AT383808B (de) Verfahren zur herstellung von penemen
DE3578062D1 (de) Verfahren zur herstellung von iodbenzol.
AT379979B (de) Verfahren zur herstellung von schleifmitteln
ATA337285A (de) Verfahren zur herstellung von isosilybinfreiem silibinin
DE3585219D1 (de) Verfahren zur herstellung von n-formyl-alpha-aspartyl-phenylalaninen.
AT386829B (de) Verfahren zur herstellung von imidazo-rifamycinen
DE3579858D1 (de) Verfahren zur herstellung von p-isobutylstyrol.
DE3575133D1 (de) Verfahren zur herstellung von 1-alkyl- oder 1-cycloalkylpiperazinen.
DE3584754D1 (de) Verfahren zur herstellung von arylalkylketonen.
ATA199684A (de) Verfahren zur herstellung von 6-deoxyanthracyclinonen
DE3581667D1 (de) Verfahren zur herstellung von 5-deoxy-l-arabinose.
AT387716B (de) Verfahren zur herstellung von 2-brom-alphaergocriptin enthaltenden zusammensetzungen
DE3576816D1 (de) Verfahren zur herstellung von chlor-o-nitroanilinen.
ATA178085A (de) Verfahren zur herstellung von 1-thiosubstituierten n-methyl-2-nitroaethenaminen
DE3580751D1 (de) Verfahren zur herstellung von acyl-lactam-verbindungen.
ATA252985A (de) Verfahren zur herstellung von
AT380480B (de) Verfahren zur herstellung von anthracyclinglykosiden
ATA25485A (de) Verfahren zur herstellung von pteridinverbindungen
AT381929B (de) Verfahren zur herstellung von succinylobernstein- saeuredialkylestern
DE3580867D1 (de) Verfahren zur herstellung von substituierten halomethyl-s-triazinen.

Legal Events

Date Code Title Description
SZA Application filed for a certificate of protection

Free format text: SZ68/94, 941207

SZZ Certificate of protection withdrawn

Free format text: SZ 68/94, 07121994

ELA Expired due to lapse of time